Skip to main content
. 2016 Nov 10;6:36447. doi: 10.1038/srep36447

Table 1. The basic clinical features of all 232 lung ADC patients and 161 cases with survival information.

Clinical Features N1 = 232 N2 = 161
Age
 ≤60 107(46.1) 75(46.6)
 >60 123(53.0) 84(52.2)
 Unknown 2(0.9) 2(1.2)
Gender
 Female 109(47.0) 75(46.6)
 Male 123(53.0) 86(53.4)
Tumor Size
 ≤3 cm 85(36.6) 63(39.1)
 >3 cm 147(63.4) 98(60.9)
Pathological Gradeb
 I 11(4.8) 11 (6.9)
 II 169(72.8) 115 (71.4)
 III 52(22.4) 35(21.7)
AJCC7 Stagea
 I 88(37.9) 53(32.9)
 II 48(20.7) 32(19.9)
 III 71(30.6) 55(34.2)
 IV 5(2.2) 1(0.6)
 Unknown 20(8.6) 20(12.4)
Lymph Node Metastasis
 Positive 110(47.4) 82(50.9)
 Negative 117(50.4) 74(46.0)
 Unknown 5(2.2) 5(3.1)
Tumor Type
 Pure Adenocarcinoma 179(77.2) 122(75.8)
 Other 53(22.8) 39(24.2)

aClinical stage was classified according to the 7th edition of the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging system. bPathological Grade was classified according to the criteria of the 2004 World Health Organization pathological grade system.